Subscribe to RSS
DOI: 10.1055/s-0028-1091398
Does Indomethacin Prevent Preterm Birth in Women with Cervical Dilatation in the Second Trimester?
Publication History
Publication Date:
19 November 2008 (online)
ABSTRACT
We sought to estimate the effect of indomethacin on duration of pregnancy in women with dilated cervix between 140/7 to 256/7 weeks. Demographics, risk factors, and outcomes were compared in women 140/7 to 256/7 weeks with a dilated cervix ≥ 1 cm who received indomethacin versus no indomethacin therapy, stratified for cerclage. Primary outcome was interval from presentation until delivery. Of 222 singleton gestations, 68 (31%) received indomethacin. In unadjusted and adjusted analyses, no significant differences were observed in interval from presentation to delivery and preterm birth < 28, < 32, or < 35 weeks comparing the indomethacin and no indomethacin groups, even after stratification for cerclage. In multivariate logistic regression analysis limited to women receiving cerclage, preterm birth < 32 weeks (odds ratio 0.56, 95% confidence interval 0.26, 1.25) and < 35 weeks (odds ratio 0.52, 95% confidence interval 0.23, 1.14) suggested a possible but not significant benefit for indomethacin use. Indomethacin therapy in women with dilated cervix at 140/7 to 256/7 weeks, regardless of cerclage or not, had no effect on pregnancy outcomes.
KEYWORDS
Indomethacin - cervical dilatation - preterm labor - cerclage
REFERENCES
- 1 Lawn J, McCarthy B J, Ross S R. The Healthy Newborn: A Reference Manual for Program Managers. Atlanta GA; Centers for Disease Control, CARE 2001: 1.20
- 2 Hamilton B E, Martin J A, Ventura S J. Births: Preliminary Data for 2005. National Vital Statistics Reports, Vol. 55. Hyattsville, MD; National Center for Health Statistics 2007
- 3 Lumley J. Defining the problem: the epidemiology of preterm birth. BJOG. 2003; 110 3-7
- 4 Novy M J, Gupta A, Wothe D D, Gupta S, Kennedy K A, Gravett M G. Cervical cerclage in the second trimester of pregnancy: a historical cohort study. Am J Obstet Gynecol. 2001; 184 1447-1454
- 5 Olatunbosun O A, Al-Nuaim L, Turnell R W. Emergent cerclage compared with bed rest for advanced cervical dilatation in pregnancy. Int Surg. 1995; 80 170-174
- 6 Daskalakis G, Papantoniou N, Mesogitis S, Antsaklis A. Management of cervical insufficiency and bulging fetal membranes. Obstet Gynecol. 2006; 107 221-226
- 7 Althuisius S M, Dekker G A, Hummel P, van Geijn H P. Cervical incompetence prevention randomized cerclage trial: emergency cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol. 2003; 189 907-910
- 8 Berghella V, Rust O A, Althuisius S M. Short cervix on ultrasound: does indomethacin prevent preterm birth?. Am J Obstet Gynecol. 2006; 195 809-813
- 9 Gibbs R S, Blanco J D, St Clair P J, Castaneda Y S. Quantitative bacteriology of amniotic fluid from women with clinical intra-amniotic infection at term. J Infect Dis. 1982; 145 1-8
- 10 Pereira L, Cotter A, Gómez R et al.. Expectant management compared with physical examination-indicated cerclage (EM-PEC) in selected women with a dilated cervix at 14 0/7 to 25 6/7 weeks: results from the EM-PEC international cohort study. ACOG. 2007; 197 483-485
- 11 Norton M E, Merrill J, Cooper B AB, Kuller J A, Clyman R I. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med. 1993; 329 1602-1607
- 12 King J, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev. 2005; CD001992
- 13 Loe S M, Sanchez-Ramos L, Kaunitz A. Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis. Obstet Gynecol. 2005; 106 173-179
- 14 Savage A H, Anderson B L, Simhan H N. The safety of prolonged indomethacin therapy. Am J Perinatol. 2007; 24 207-213
Vincenzo BerghellaM.D.
Thomas Jefferson University, Department of Obstetrics and Gynecology
834 Chestnut Street, Suite 400 Philadelphia, PA 19107
Email: vincenzo.berghella@jefferson.edu